Biotest Aktiengesellschaft (ETR:BIO – Get Free Report)’s stock price was down 0.5% during mid-day trading on Thursday . The stock traded as low as €41.20 ($42.47) and last traded at €41.20 ($42.47). Approximately 46 shares were traded during trading, a decline of 98% from the average daily volume of 1,927 shares. The stock had previously closed at €41.40 ($42.68).
Biotest Aktiengesellschaft Price Performance
The company has a market capitalization of $819.31 million, a price-to-earnings ratio of 9.98 and a beta of 0.24. The company has a debt-to-equity ratio of 116.50, a current ratio of 2.45 and a quick ratio of 1.66. The firm’s fifty day moving average price is €41.46 and its 200-day moving average price is €41.64.
About Biotest Aktiengesellschaft
Biotest Aktiengesellschaft develops, manufactures, and sells biological and biotechnological pharmaceutical products in Germany and internationally. It operates through three segments: European Union, Rest of the World, and Stateless. The company specializes primarily in the therapeutic areas of clinical immunology, haematology, and intensive care medicine.
See Also
- Five stocks we like better than Biotest Aktiengesellschaft
- How to Use the MarketBeat Stock Screener
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- Differences Between Momentum Investing and Long Term Investing
- Nebius Group: The Rising Star in AI Infrastructure
- Consumer Staples Stocks, Explained
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for Biotest Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotest Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
